Licarbazepine
Licarbazepine, also known as BIA-2-005; GP-47779; LIC-477; LIC-477D; TRI-477, is a voltage-gated sodium channel blocker with anticonvulsant and mood-stabilizing effects that is related to oxcarbazepine. It is an active metabolite of oxcarbazepine. In addition, an isomer of licarbazepine, eslicarbazepine ((S)-(+)-licarbazepine), is an active metabolite of eslicarbazepine acetate. Oxcarbazepine and eslicarbazepine acetate are inactive on their own, and behave instead as prodrugs to licarbazepine and eslicarbazepine, respectively, to produce their therapeutic effects.
Trivial name | BIA-2-005;GP-47779;LIC-477;LIC-477D;TRI-477 |
Catalog Number | CSN25458 |
Alternative Name(s) | BIA-2-005;GP-47779;LIC-477;LIC-477D;TRI-477 |
Research Area | / |
Molecular Formula | C15H14N2O2 |
CAS# | 29331-92-8 |
Purity | ≥97% |
SMILES | O=C(N1C2=CC=CC=C2CC(O)C3=CC=CC=C31)N |
Size | 100mg |
Supplier Page | https://www.csnpharm.com/products/10-hydroxy-10,11-dihydro-5h-dibenzo[b,f]azepine-5-carboxamide.html |